$HAL
HALLIBURTON CO

2023 Q2 Form 10-Q Financial Statement

#000004501223000027 Filed on April 26, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q1
Revenue $5.798B $5.677B $4.284B
YoY Change 14.27% 32.52% 24.14%
Cost Of Revenue $4.720B $4.646B $3.699B
YoY Change 10.05% 25.6% 21.96%
Gross Profit $1.078B $1.031B $585.0M
YoY Change 37.32% 76.24% 39.95%
Gross Profit Margin 18.59% 18.16% 13.66%
Selling, General & Admin $54.00M $54.00M $52.00M
YoY Change -19.4% 3.85% 8.33%
% of Gross Profit 5.01% 5.24% 8.89%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $245.0M $241.0M $232.0M
YoY Change 2.94% 3.88% 2.65%
% of Gross Profit 22.73% 23.38% 39.66%
Operating Expenses $67.00M $54.00M $52.00M
YoY Change 0.0% 3.85% 8.33%
Operating Profit $1.011B $977.0M $511.0M
YoY Change 170.32% 91.19% 38.11%
Interest Expense -$92.00M -$79.00M -$107.0M
YoY Change -8.91% -26.17% -14.4%
% of Operating Profit -9.1% -8.09% -20.94%
Other Income/Expense, Net -$32.00M -$69.00M -$30.00M
YoY Change -23.81% 130.0% 36.36%
Pretax Income $783.0M $829.0M $332.0M
YoY Change 238.96% 149.7% 48.88%
Income Tax $167.0M $174.0M $68.00M
% Of Pretax Income 21.33% 20.99% 20.48%
Net Earnings $610.0M $651.0M $263.0M
YoY Change 459.63% 147.53% 54.71%
Net Earnings / Revenue 10.52% 11.47% 6.14%
Basic Earnings Per Share $680.0K $720.0K $290.0K
Diluted Earnings Per Share $0.68 $720.0K $291.3K
COMMON SHARES
Basic Shares Outstanding 902.2M shares 904.1M shares 899.0M shares
Diluted Shares Outstanding 903.0M shares 907.0M shares 903.0M shares

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.105B $1.879B $2.154B
YoY Change -5.44% -12.77% -11.94%
Cash & Equivalents $2.105B $1.879B $2.154B
Short-Term Investments
Other Short-Term Assets $1.151B $1.038B $959.0M
YoY Change 16.03% 8.24% -34.98%
Inventory $3.241B $3.133B $2.578B
Prepaid Expenses
Receivables $4.946B $5.195B $4.026B
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $11.44B $11.25B $9.717B
YoY Change 11.51% 15.73% 2.07%
LONG-TERM ASSETS
Property, Plant & Equipment $5.537B $4.399B $4.270B
YoY Change 32.94% 3.02% 0.92%
Goodwill $2.840B $2.829B $2.850B
YoY Change 0.42% -0.74% 1.64%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $4.253B $1.632B $1.580B
YoY Change 166.98% 3.29% 44.29%
Total Long-Term Assets $12.63B $12.37B $12.36B
YoY Change 3.67% 0.15% 11.77%
TOTAL ASSETS
Total Short-Term Assets $11.44B $11.25B $9.717B
Total Long-Term Assets $12.63B $12.37B $12.36B
Total Assets $24.07B $23.62B $22.07B
YoY Change 7.25% 7.0% 7.28%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.188B $3.180B $2.561B
YoY Change 14.1% 24.17% 44.77%
Accrued Expenses $1.170B $701.0M $938.0M
YoY Change 8.64% -25.27% 28.67%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $5.346B $5.266B $4.444B
YoY Change 12.17% 18.5% 5.18%
LONG-TERM LIABILITIES
Long-Term Debt $7.931B $7.929B $8.530B
YoY Change -6.97% -7.05% -6.54%
Other Long-Term Liabilities $2.069B $790.0M $791.0M
YoY Change 174.4% -0.13% -2.1%
Total Long-Term Liabilities $10.00B $790.0M $791.0M
YoY Change 1226.26% -0.13% -2.1%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.346B $5.266B $4.444B
Total Long-Term Liabilities $10.00B $790.0M $791.0M
Total Liabilities $15.38B $15.17B $15.04B
YoY Change 0.54% 0.89% -2.31%
SHAREHOLDERS EQUITY
Retained Earnings $11.46B $11.08B $9.780B
YoY Change 19.15% 13.24% 12.3%
Common Stock $2.663B $2.664B $2.665B
YoY Change -0.08% -0.04% -1.3%
Preferred Stock
YoY Change
Treasury Stock (at cost) $5.201B $5.095B $5.250B
YoY Change 4.58% -2.95% -10.67%
Treasury Stock Shares 167.0M shares 163.0M shares 165.0M shares
Shareholders Equity $8.693B $8.415B $7.017B
YoY Change
Total Liabilities & Shareholders Equity $24.07B $23.62B $22.07B
YoY Change 7.25% 7.0% 7.28%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q1
OPERATING ACTIVITIES
Net Income $610.0M $651.0M $263.0M
YoY Change 459.63% 147.53% 54.71%
Depreciation, Depletion And Amortization $245.0M $241.0M $232.0M
YoY Change 2.94% 3.88% 2.65%
Cash From Operating Activities $1.052B $122.0M -$50.00M
YoY Change 179.79% -344.0% -124.63%
INVESTING ACTIVITIES
Capital Expenditures $303.0M $268.0M -$189.0M
YoY Change -237.1% -241.8% 81.73%
Acquisitions
YoY Change
Other Investing Activities -$98.00M $68.00M $22.00M
YoY Change -450.0% 209.09% 37.5%
Cash From Investing Activities -$401.0M -$295.0M -$155.0M
YoY Change 107.77% 90.32% 150.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $0.00 $640.0M
YoY Change -100.0% 240.43%
Cash From Financing Activities -395.0M -$249.0M -$668.0M
YoY Change 426.67% -62.72% 199.55%
NET CHANGE
Cash From Operating Activities 1.052B $122.0M -$50.00M
Cash From Investing Activities -401.0M -$295.0M -$155.0M
Cash From Financing Activities -395.0M -$249.0M -$668.0M
Net Change In Cash 256.0M -$467.0M -$890.0M
YoY Change 137.04% -47.53% 660.68%
FREE CASH FLOW
Cash From Operating Activities $1.052B $122.0M -$50.00M
Capital Expenditures $303.0M $268.0M -$189.0M
Free Cash Flow $749.0M -$146.0M $139.0M
YoY Change 25.46% -205.04% -54.72%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 hal Number Of Business Segments
NumberOfBusinessSegments
2 division
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000045012
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
902194900 shares
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
001-03492
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
HALLIBURTON COMPANY
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
75-2677995
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
3000 North Sam Houston Parkway East,
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Houston,
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
77032
CY2023Q1 dei City Area Code
CityAreaCode
281
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
871-2699
CY2023Q1 dei Security12b Title
Security12bTitle
Common Stock, par value $2.50 per share
CY2023Q1 dei Trading Symbol
TradingSymbol
HAL
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
902194900 shares
CY2023Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
5677000000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
4284000000 usd
CY2023Q1 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
0 usd
CY2022Q1 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
22000000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
54000000 usd
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
52000000 usd
CY2023Q1 us-gaap Costs And Expenses
CostsAndExpenses
4700000000 usd
CY2022Q1 us-gaap Costs And Expenses
CostsAndExpenses
3773000000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
977000000 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
511000000 usd
CY2023Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
39000000 usd
CY2022Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
19000000 usd
CY2023Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-79000000 usd
CY2022Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-107000000 usd
CY2023Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2022Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-42000000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-69000000 usd
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-30000000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
829000000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
332000000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
174000000 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
68000000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
655000000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
264000000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
4000000 usd
CY2022Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1000000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
651000000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
263000000 usd
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
720000
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
720000
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
290000
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
290000
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
904000000 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
899000000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
907000000 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
903000000 shares
CY2023Q1 us-gaap Profit Loss
ProfitLoss
655000000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
264000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1000000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
5000000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
656000000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
269000000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
4000000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
1000000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
652000000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
268000000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1879000000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2346000000 usd
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
720000000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
731000000 usd
CY2023Q1 us-gaap Receivables Net Current
ReceivablesNetCurrent
5195000000 usd
CY2022Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
4627000000 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
3133000000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
2923000000 usd
CY2023Q1 us-gaap Other Assets Current
OtherAssetsCurrent
1038000000 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
1056000000 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
11245000000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
10952000000 usd
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
11689000000 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
11660000000 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4399000000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4348000000 usd
CY2023Q1 us-gaap Goodwill
Goodwill
2829000000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
2829000000 usd
CY2023Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
2574000000 usd
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
2636000000 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
940000000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
913000000 usd
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1632000000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1577000000 usd
CY2023Q1 us-gaap Assets
Assets
23619000000 usd
CY2022Q4 us-gaap Assets
Assets
23255000000 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
3180000000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3121000000 usd
CY2023Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
474000000 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
634000000 usd
CY2023Q1 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
299000000 usd
CY2022Q4 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
349000000 usd
CY2023Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
293000000 usd
CY2022Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
294000000 usd
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
227000000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
224000000 usd
CY2023Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
793000000 usd
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
723000000 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
5266000000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5345000000 usd
CY2023Q1 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
7929000000 usd
CY2022Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
7928000000 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
812000000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
791000000 usd
CY2023Q1 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
377000000 usd
CY2022Q4 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
408000000 usd
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
790000000 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
806000000 usd
CY2023Q1 us-gaap Liabilities
Liabilities
15174000000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
15278000000 usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
2.50
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
2.50
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
2000000000 shares
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
8415000000 usd
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
2000000000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1065000000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1066000000 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
2664000000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
2664000000 usd
CY2023Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
0 usd
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
50000000 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-229000000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-230000000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
11075000000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
10572000000 usd
CY2023Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
163000000 shares
CY2022Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
164000000 shares
CY2023Q1 us-gaap Treasury Stock Value
TreasuryStockValue
5095000000 usd
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
5108000000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
7948000000 usd
CY2023Q1 us-gaap Minority Interest
MinorityInterest
30000000 usd
CY2022Q4 us-gaap Minority Interest
MinorityInterest
29000000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
8445000000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
7977000000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
23619000000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
23255000000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
655000000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
264000000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
241000000 usd
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
232000000 usd
CY2023Q1 us-gaap Restructuring Charges
RestructuringCharges
0 usd
CY2022Q1 us-gaap Restructuring Charges
RestructuringCharges
22000000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
575000000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
368000000 usd
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
210000000 usd
CY2022Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
225000000 usd
CY2023Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-189000000 usd
CY2022Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-87000000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
57000000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
207000000 usd
CY2023Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-143000000 usd
CY2022Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
95000000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
122000000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-50000000 usd
CY2023Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
268000000 usd
CY2022Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
189000000 usd
CY2023Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
41000000 usd
CY2022Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
56000000 usd
CY2023Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
68000000 usd
CY2022Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
22000000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-295000000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-155000000 usd
CY2023Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
145000000 usd
CY2022Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
108000000 usd
CY2023Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
100000000 usd
CY2022Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 usd
CY2023Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0 usd
CY2022Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
640000000 usd
CY2023Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-4000000 usd
CY2022Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
80000000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-249000000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-668000000 usd
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-45000000 usd
CY2022Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-17000000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-467000000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-890000000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2346000000 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3044000000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1879000000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2154000000 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
127000000 usd
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
134000000 usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
148000000 usd
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
78000000 usd
CY2023Q1 us-gaap Basis Of Accounting
BasisOfAccounting
Basis of Presentation<div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited condensed consolidated financial statements were prepared using generally accepted accounting principles for interim financial information and the instructions to Form 10-Q and Regulation S-X. Accordingly, these financial statements do not include all information or notes required by generally accepted accounting principles for annual financial statements and should be read together with our 2022 Annual Report on Form 10-K.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our accounting policies are in accordance with United States generally accepted accounting principles. The preparation of financial statements in conformity with these accounting principles requires us to make estimates and assumptions that affect:</span></div><div style="margin-bottom:3pt;padding-left:49.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements; and</span></div><div style="padding-left:49.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">the reported amounts of revenue and expenses during the reporting period.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ultimate results could differ from our estimates.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In our opinion, the condensed consolidated financial statements included herein contain all adjustments necessary to present fairly our financial position as of March 31, 2023 and the results of our operations for the three months ended March 31, 2023 and 2022, and our cash flows for the three months ended March 31, 2023 and 2022. Such adjustments are of a normal recurring nature. In addition, certain reclassifications of prior period balances have been made to conform to the current period presentation.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The results of our operations for the three months ended March 31, 2023 may not be indicative of results for the full year.</span></div>
CY2023Q1 hal Number Of Business Segments
NumberOfBusinessSegments
2 division
CY2023Q1 hal Number Of Business Segments
NumberOfBusinessSegments
2 division
CY2023Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
5677000000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
4284000000 usd
CY2023Q1 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
0 usd
CY2022Q1 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
22000000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
977000000 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
511000000 usd
CY2023Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-79000000 usd
CY2022Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-107000000 usd
CY2023Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2022Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-42000000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-69000000 usd
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-30000000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
829000000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
332000000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
5677000000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
4284000000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
5677000000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
4284000000 usd
CY2023Q1 us-gaap Revenue Performance Obligation Description Of Timing
RevenuePerformanceObligationDescriptionOfTiming
one year
CY2023Q1 hal Number Of Customers Exceed Receivables Threshold
NumberOfCustomersExceedReceivablesThreshold
0 customers
CY2022Q4 hal Number Of Customers Exceed Receivables Threshold
NumberOfCustomersExceedReceivablesThreshold
0 customers
CY2022Q4 hal Maximum Percentage Gross Trade Receivables From One Customer
MaximumPercentageGrossTradeReceivablesFromOneCustomer
0.10
CY2023Q1 hal Maximum Percentage Gross Trade Receivables From One Customer
MaximumPercentageGrossTradeReceivablesFromOneCustomer
0.10
CY2023Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
1995000000 usd
CY2022Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
1859000000 usd
CY2023Q1 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
1011000000 usd
CY2022Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
953000000 usd
CY2023Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
127000000 usd
CY2022Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
111000000 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
3133000000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
2923000000 usd
CY2023Q1 hal Outstanding Supplier Finance Payment Obligation
OutstandingSupplierFinancePaymentObligation
321000000 usd
CY2022Q4 hal Outstanding Supplier Finance Payment Obligation
OutstandingSupplierFinancePaymentObligation
273000000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
174000000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
829000000 usd
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.210
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
68000000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
332000000 usd
CY2022Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.205
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
7977000000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
655000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1000000 usd
CY2023Q1 us-gaap Dividends Common Stock
DividendsCommonStock
145000000 usd
CY2023Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
100000000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
60000000 usd
CY2023Q1 us-gaap Stockholders Equity Other
StockholdersEquityOther
3000000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
8445000000 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
6728000000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
264000000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
5000000 usd
CY2022Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.12
CY2022Q1 us-gaap Dividends Common Stock
DividendsCommonStock
108000000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
144000000 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
7033000000 usd
CY2023Q1 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
2900000 shares
CY2023Q1 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
4800000000 usd
CY2023Q1 hal Treasury Stock Shares Acquired From Inception
TreasuryStockSharesAcquiredFromInception
234000000 shares
CY2023Q1 hal Treasury Stock Value Acquired Cost Method From Inception
TreasuryStockValueAcquiredCostMethodFromInception
9400000000 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-83000000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-84000000 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Defined Benefit Pension And Other Postretirement Plans Net Of Tax
AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
102000000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Defined Benefit Pension And Other Postretirement Plans Net Of Tax
AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
101000000 usd
CY2023Q1 hal Accumulated Other Comprehensive Income Loss Other Net Of Tax
AccumulatedOtherComprehensiveIncomeLossOtherNetOfTax
-44000000 usd
CY2022Q4 hal Accumulated Other Comprehensive Income Loss Other Net Of Tax
AccumulatedOtherComprehensiveIncomeLossOtherNetOfTax
-45000000 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-229000000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-230000000 usd
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
904000000 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
899000000 shares
CY2023Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
3000000 shares
CY2022Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
4000000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
907000000 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
903000000 shares
CY2023Q1 hal Numberofdaysfromperiodend
Numberofdaysfromperiodend
P2D
CY2023Q1 hal Numberofdaysfromperiodend
Numberofdaysfromperiodend
P2D
CY2023Q1 hal Gap Between Official Exchange Rate And Implicit Exchange Rate
GapBetweenOfficialExchangeRateAndImplicitExchangeRate
0.94

Files In Submission

Name View Source Status
hal-20230331_cal.xml Edgar Link unprocessable
0000045012-23-000027-index-headers.html Edgar Link pending
0000045012-23-000027-index.html Edgar Link pending
0000045012-23-000027.txt Edgar Link pending
0000045012-23-000027-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
hal-20230331.htm Edgar Link pending
hal-20230331.xsd Edgar Link pending
hal-20230331_g1.jpg Edgar Link pending
hal-20230331_g2.jpg Edgar Link pending
hal-20230331_g3.jpg Edgar Link pending
hal_03312023-ex101.htm Edgar Link pending
hal_03312023-ex311.htm Edgar Link pending
hal_03312023-ex312.htm Edgar Link pending
hal_03312023-ex321.htm Edgar Link pending
hal_03312023-ex322.htm Edgar Link pending
hal_03312023-ex95.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
hal-20230331_def.xml Edgar Link unprocessable
hal-20230331_lab.xml Edgar Link unprocessable
hal-20230331_pre.xml Edgar Link unprocessable
hal-20230331_htm.xml Edgar Link completed
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending